Hyperlipidemia ICD-10 Code: A Coding and Billing Guide

Hyperlipidemia describes an abnormal level of lipids in the blood, including cholesterol and triglycerides. In ICD 10 CM, hyperlipidemia falls under category E78, disorders of lipoprotein metabolism and other lipidemias. The most commonly used general code is E78.5, hyperlipidemia, unspecified, but practices should use a more specific E78 code when the provider documents the type of lipid disorder. E78.5 remains a billable ICD-10-CM code for fiscal year 2026.

For healthcare providers and billing teams, correct coding involves more than matching a cholesterol result to an ICD-10 code. The medical record should establish the diagnosis, support the services performed, explain medical necessity when appropriate, and give the coder enough information to select the most specific supported code.

What Is Hyperlipidemia?

Hyperlipidemia occurs when a patient has an abnormal amount or balance of lipids in the blood. These lipids include cholesterol and triglycerides.

The condition can involve elevated low-density lipoprotein cholesterol, elevated triglycerides, low high-density lipoprotein cholesterol, or a combination of lipid abnormalities.

Providers may discover hyperlipidemia during routine laboratory testing or while evaluating a patient with cardiovascular risk factors. Once diagnosed, the condition may require ongoing monitoring, lifestyle counseling, medication management, and repeat laboratory testing.

From a billing perspective, the provider should distinguish between a laboratory finding and a documented diagnosis.

For example, a laboratory report may show an elevated LDL level. That result alone does not tell the coder whether the provider considers the patient to have pure hypercholesterolemia, mixed hyperlipidemia, familial hypercholesterolemia, or unspecified hyperlipidemia.

The provider’s assessment should make that distinction whenever the clinical information supports it.

What Is the ICD-10 Code for Hyperlipidemia?

The answer depends on what the provider documents.

E78.5 means hyperlipidemia, unspecified. It is a billable code under the current 2026 ICD-10-CM code set.

However, E78.5 is not the only code available.

Common E78 codes include:

The key point for coders is simple: do not automatically assign E78.5 whenever the chart mentions high cholesterol. Review the provider’s assessment and determine whether the documentation supports a more specific E78 diagnosis.

E78.5: Hyperlipidemia, Unspecified

E78.5 represents hyperlipidemia, unspecified. The code remains billable and valid for fiscal year 2026.

This code fits documentation such as:

Hyperlipidemia, unspecified. Continue current lipid-lowering therapy and repeat lipid panel.

It may also apply when the provider documents hyperlipidemia but does not identify the specific type and the available record does not support further specificity.

The problem occurs when coders use E78.5 even though the provider has clearly documented a more specific condition.

For example, if the provider documents mixed hyperlipidemia, E78.2 may be more appropriate than E78.5.

If the provider documents familial hypercholesterolemia, E78.01 may apply.

The coder should not infer a diagnosis solely from laboratory values. The record should support the diagnosis reported on the claim.

E78.00: Pure Hypercholesterolemia, Unspecified

E78.00 identifies pure hypercholesterolemia when the provider documents that condition but does not identify familial hypercholesterolemia.

The provider should document the clinical diagnosis rather than simply copying a cholesterol result into the assessment.

A useful note could state:

Pure hypercholesterolemia. LDL remains elevated despite current therapy. Continue treatment and repeat lipid testing to evaluate response.

This documentation gives the coder a diagnosis, relevant laboratory information, treatment status, and a reason for continued monitoring.

E78.01: Familial Hypercholesterolemia

E78.01 identifies familial hypercholesterolemia.

This diagnosis requires appropriate clinical documentation. A very high LDL level does not automatically justify assigning familial hypercholesterolemia.

When the provider diagnoses this condition, the record should support the assessment through relevant history and clinical findings.

Useful documentation may include:

• Familial hypercholesterolemia diagnosis
• Relevant family history
• Previous lipid results
• Treatment history
• Response to lipid-lowering therapy
• Current treatment plan
• Ongoing monitoring

The coder should not independently establish familial hypercholesterolemia from a laboratory result.

E78.1: Pure Hyperglyceridemia

E78.1 describes pure hyperglyceridemia.

The provider should identify the condition when elevated triglycerides represent the documented lipid disorder.

A strong assessment might state:

Pure hyperglyceridemia. Triglycerides remain elevated on current therapy. Continue dietary counseling and medication. Repeat lipid panel at follow-up.

The billing team can then connect the diagnosis with the services documented during the encounter.

E78.2: Mixed Hyperlipidemia

E78.2 identifies mixed hyperlipidemia.

Providers commonly use this diagnosis when the patient has more than one lipid abnormality that the provider characterizes as mixed hyperlipidemia.

For example:

Mixed hyperlipidemia with elevated LDL and triglycerides. Continue current medication and repeat lipid panel to assess treatment response.

That documentation provides a stronger coding basis than a note that simply says “high cholesterol.”

E78.41: Elevated Lipoprotein(a)

E78.41 identifies elevated lipoprotein(a), commonly called Lp(a).

When a provider evaluates or manages elevated Lp(a), the diagnosis should appear clearly in the assessment.

The provider should also document why the condition matters to the patient’s care and what monitoring or treatment plan applies.

Coders should avoid replacing a documented E78.41 diagnosis with a generic E78.5 code merely because both belong to the E78 family.

E78.49: Other Hyperlipidemia

E78.49 covers other hyperlipidemia.

This code differs from unspecified hyperlipidemia.

Other means the provider has documented a specific condition that does not fit one of the more narrowly defined categories.

Unspecified means the provider has not given enough detail to identify the type.

That distinction matters because coders should not use E78.49 simply because they want to avoid E78.5.

The documentation must support the choice.

E78.9: Disorder of Lipoprotein Metabolism, Unspecified

E78.9 identifies an unspecified disorder of lipoprotein metabolism.

It should not automatically replace E78.5.

E78.5 describes unspecified hyperlipidemia, while E78.9 describes an unspecified disorder of lipoprotein metabolism.

The provider’s exact diagnostic wording matters.

Hyperlipidemia Documentation Requirements

Good documentation gives the coder enough information to select the correct diagnosis without guessing.

For an established hyperlipidemia diagnosis, the provider should document the condition in the assessment and explain its current status.

Useful documentation includes:

Specific diagnosis

Document the type when clinically established.

Examples include:

• Pure hypercholesterolemia
• Familial hypercholesterolemia
• Pure hyperglyceridemia
• Mixed hyperlipidemia
• Elevated lipoprotein(a)
• Other hyperlipidemia
• Hyperlipidemia, unspecified

Relevant laboratory findings

The provider should review relevant lipid results when they influence treatment or monitoring.

The note does not need to repeat every value from the laboratory report. A concise clinical interpretation can work better.

For example:

LDL remains elevated despite current treatment.

That statement provides context for the management decision.

Current treatment

Document relevant treatment when the provider manages the condition.

This may include:

• Statin therapy
• Other lipid-lowering medication
• Dietary changes
• Exercise recommendations
• Medication adjustment
• Treatment adherence
• Follow-up testing

Clinical status

The provider should document whether the condition remains controlled, uncontrolled, improved, worsened, or otherwise requires management.

Avoid copying the same phrase into every visit without reviewing the patient’s current status.

Follow-up plan

Document what happens next.

For example:

Continue current therapy and repeat lipid panel at the next follow-up visit.

That connects the diagnosis with ongoing management.

Hyperlipidemia and Lipid Panel Billing

A lipid panel commonly uses CPT 80061.

CMS includes CPT 80061, lipid panel, in its Medicare lipid testing policy. The same policy also addresses individual lipid measurements, including total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides.

When a practice bills a lipid panel, the diagnosis should support the reason for the test.

For example:

Assessment: Mixed hyperlipidemia. LDL and triglycerides remain elevated. Repeat lipid panel to evaluate response to current therapy.

The billing team can then report the documented diagnosis with the laboratory service, subject to the payer’s coverage requirements.

A diagnosis code does not automatically guarantee payment. The payer can still review medical necessity, frequency, coverage, documentation, and other claim requirements.

Medical Necessity for Hyperlipidemia Testing

Medical necessity plays a major role in laboratory reimbursement.

CMS’s National Coverage Determination for lipid testing explains that lipid testing can help evaluate and monitor treatment and cardiovascular risk. CMS also states that more frequent testing may become appropriate when a patient has marked lipid elevations or when the provider changes lipid therapy because the patient has not responded adequately.

The same policy notes that once treatment goals have been achieved, LDL cholesterol or total cholesterol may be measured up to three times per year under the circumstances described by the policy.

Practices should therefore avoid treating every repeat lipid panel as automatically payable.

The documentation should explain why the provider ordered the test.

Ask:

• What condition is being monitored?
• What changed since the previous test?
• Is the provider monitoring treatment?
• Did the provider change medication?
• Does the payer’s policy support the frequency?

The answers should appear in the clinical record when relevant.

Hyperlipidemia Coding and Reimbursement

Correct diagnosis coding supports the claim, but reimbursement depends on several factors.

Payers may consider:

• Patient benefits
• Coverage rules
• Medical necessity
• Provider network status
• CPT or HCPCS code
• ICD-10-CM diagnosis
• Documentation
• Frequency limitations
• Claim edits
• Payer-specific policies

A claim can contain a valid E78.5 code and still receive a denial if the service does not meet the payer’s coverage requirements.

That distinction matters for billing teams.

Correct coding does not equal guaranteed payment.

Instead, correct coding gives the claim an accurate clinical foundation.

How Hyperlipidemia Documentation Supports Reimbursement

Consider a patient receiving ongoing lipid management.

The provider reviews the latest laboratory results, discusses medication adherence, continues treatment, and orders another lipid panel.

A useful note could state:

Mixed hyperlipidemia. LDL remains above the patient’s treatment goal. Patient reports adherence to current medication. Continue therapy and repeat lipid panel to assess response.

This note supports several parts of the billing record:

• Diagnosis: Mixed hyperlipidemia
• Clinical finding: LDL remains elevated
• Treatment: Current medication continues
• Medical decision: Provider continues active management
• Testing: Repeat lipid panel

The billing team still needs to check the payer’s specific requirements, but the documentation gives the claim a much stronger foundation.

Common Hyperlipidemia Coding Mistakes

Using E78.5 for Every Patient With High Cholesterol

This mistake happens when coders treat E78.5 as the default code for every abnormal lipid result.

E78.5 means unspecified hyperlipidemia. It should not replace a more specific documented diagnosis.

How to avoid it

Review the provider’s assessment before assigning E78.5.

Look for documentation of:

• Pure hypercholesterolemia

• Familial hypercholesterolemia

• Pure hyperglyceridemia

• Mixed hyperlipidemia

• Elevated lipoprotein(a)

• Other hyperlipidemia

If the provider documents a specific diagnosis, code that diagnosis when the ICD 10 CM code set supports it.

Coding From Laboratory Results Alone

A coder may see high LDL and automatically select a specific cholesterol diagnosis.

That creates a problem because coders should not independently diagnose the patient from laboratory values.

How to avoid it

Use the provider’s documented diagnosis.

If the laboratory findings appear clinically important but the provider has not documented the diagnosis clearly, follow applicable coding guidelines and query the provider when appropriate.

Reporting E78 Instead of a Billable Code

E78 represents the broader category of disorders of lipoprotein metabolism and other lipidemias.

The billing team needs a billable child code supported by the documentation.

How to avoid it

Review the complete E78 code family and select the appropriate billable code.

Ignoring the Difference Between Other and Unspecified

Coders sometimes use E78.49 simply because E78.5 seems too general.

That approach can create unsupported coding.

How to avoid it

Use E78.49 only when the provider documents a condition that fits the “other” category.

Use E78.5 when the provider documents hyperlipidemia without enough specificity to identify the type.

Billing a Lipid Panel Without Supporting Documentation

A practice may submit CPT 80061 with an E78 diagnosis but fail to document why the provider ordered repeat testing.

That can create medical necessity problems.

How to avoid it

Document the diagnosis, relevant laboratory findings, treatment status, and reason for monitoring.

CMS’s lipid testing policy specifically addresses medical necessity and testing frequency.

Repeating Lipid Testing Without Reviewing Frequency

Repeated testing can make clinical sense, especially after medication changes or inadequate response.

However, the billing team should still review applicable payer requirements.

How to avoid it

Check the patient’s previous testing date, treatment changes, clinical status, and payer policy before submitting the claim.

Hyperlipidemia and Denial Management

When a payer denies a hyperlipidemia-related claim, do not immediately change the diagnosis.

First determine why the payer denied it.

Common causes include:

Medical necessity denial

The payer does not find enough evidence that the service met its coverage requirements.

Diagnosis and procedure mismatch

The reported diagnosis does not adequately support the billed service.

Frequency issue

The practice submitted testing more often than the payer allows without adequate documentation.

Documentation problem

The provider’s note does not explain the reason for testing or treatment.

Coding error

The claim contains the wrong or unsupported ICD-10-CM code.

Each denial requires a different response.

Changing E78.5 to E78.2 without provider documentation does not solve a documentation problem. It can create a new coding problem.

How to Appeal a Hyperlipidemia-Related Denial

Start by reviewing the original claim and payer explanation.

Then compare:

• ICD-10-CM code
• CPT code
• Provider note
• Laboratory order
• Laboratory result
• Previous testing
• Medication changes
• Payer policy
• Remittance advice

If the record supports medical necessity and the payer processed the claim incorrectly, submit the appropriate appeal with the supporting documentation.

If the medical record lacks information, follow the appropriate provider query process instead of creating unsupported documentation.

How Accurate Hyperlipidemia Coding Improves Revenue

Accurate Hyperlipidemia coding does not simply help the practice submit claims. It helps the practice report the clinical reason for the service correctly.

Poor coding can lead to:

• Claim denials
• Delayed reimbursement
• Medical record requests
• Rework
• Incorrect patient balances
• Underpayment
• Audit concerns

Documentation gaps create another problem. Even when the provider performed medically appropriate work, the practice may struggle to prove medical necessity if the record does not explain the service.

A good billing process therefore starts in the exam room.

The provider documents the condition.

The coder translates that documentation into the correct ICD-10-CM code.

The billing team connects the diagnosis with the appropriate service code and payer requirements.

That chain supports cleaner claims and more reliable reimbursement.

Frequently Asked Questions

What is the ICD-10 code for hyperlipidemia?

The most commonly used code for unspecified hyperlipidemia is E78.5. It is a billable ICD-10-CM code for fiscal year 2026. However, providers and coders should use a more specific E78 code when the medical record supports a specific lipid disorder.

Is E78.5 a billable ICD-10 code?

Yes. E78.5, hyperlipidemia, unspecified, is a billable ICD-10-CM code for fiscal year 2026. The code applies when the provider documents hyperlipidemia but does not specify a more precise type supported by the medical record.

What is the difference between E78.5 and E78.2?

E78.5 describes unspecified hyperlipidemia. E78.2 describes mixed hyperlipidemia. The coder should use E78.2 when the provider documents mixed hyperlipidemia and the record supports that diagnosis. The coder should not infer mixed hyperlipidemia solely from a combination of abnormal laboratory values.

Can E78.5 support a lipid panel?

E78.5 can serve as a diagnosis code when the provider documents unspecified hyperlipidemia and the diagnosis supports the service. However, the diagnosis alone does not guarantee reimbursement. Medicare and commercial payers may apply medical necessity, frequency, coverage, and documentation requirements. CMS’s lipid testing policy addresses these requirements for Medicare.

What CPT code is used for a lipid panel?

CPT 80061 describes a lipid panel. CMS includes 80061 in its Medicare lipid testing policy. Practices should still verify the current payer policy, documentation, and coverage requirements before billing.

Can a coder assign hyperlipidemia from laboratory results?

Coders should not independently diagnose a patient from laboratory results. The provider should document the diagnosis. If the record contains abnormal lipid results but does not clearly establish the diagnosis or its type, the coder should follow applicable coding guidelines and use the provider query process when appropriate.

Why do hyperlipidemia claims get denied?

Common reasons include insufficient medical necessity documentation, incorrect diagnosis selection, testing frequency issues, diagnosis and procedure mismatches, and failure to meet payer-specific coverage requirements. CMS notes that lipid testing coverage depends on applicable medical necessity requirements and provides specific guidance concerning repeat testing.

How should providers document hyperlipidemia for billing?

Providers should document the specific lipid disorder when they can establish it, relevant laboratory findings when they affect management, current treatment, clinical status, and the follow-up plan. When the provider orders repeat lipid testing, the note should explain why the test is necessary, particularly when the payer applies frequency or medical necessity requirements.